Investors.gilead.com

Gilead Sciences, Inc.

- This Approval Supports Veklury’s Strong Safety Profile and Makes Veklury the Only Approved COVID-19 Antiviral Treatment Across all Stages of Liver Disease - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) for the use of Veklury® (remdesivir) with no dose adjustments to treat COVID-19

Actived: 7 days ago

URL: https://investors.gilead.com/news/news-details/2023/FDA-Approves-Veklury-Remdesivir-to-Treat-COVID-19-in-People-With-Mild-to-Severe-Hepatic-Impairment-With-no-Dose-Adjustment/default.aspx

Gilead Sciences, Inc.

WEB– Additional Data in Pregnant Adults Who Are Virologically Suppressed Reinforce Safety and Tolerability Profile of Biktarvy in Broad Range of People With HIV …

Category:  Health Go Health

Gilead Sciences, Inc.

WEB–Trodelvy is the First TROP-2 Directed ADC to Show a Significant Improvement in Overall Survival in HR+/HER2- Breast Cancer – – Planned …

Category:  Cancer Go Health

Gilead Awards $7.6 Million in Grants to Advance Health …

WEBFOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) awarded $7.6 million in grant funding to 24 U.S.-based, community organizations …

Category:  Health Go Health

Gilead Presents New Data From HIV Cure Research …

WEB– Innovative Investigational Approaches Include Targeting of the HIV Viral Reservoir and Enhancing Immune Response in the Absence of Antiretroviral Therapy – …

Category:  Health Go Health

Gilead Sciences Announces New Clinical Trial in Europe to …

WEB– PURPOSE 5 trial will evaluate lenacapavir as twice-yearly prevention option in people who could benefit from HIV pre-exposure prophylaxis (PrEP) in France …

Category:  Health Go Health

Gilead Sciences, Inc.

WEB– Long-Term Real-World HIV Research Offer Insights into How Treatment with Biktarvy ® and Sunlenca ® May Help Inform the Future of Coordinated, Person …

Category:  Health Go Health

Gilead Sciences, Inc.

WEB– Funding Will Support the Re-Engagement of Diagnosed but Untreated People Living with HCV and HBV in the United States into Care – Gilead Sciences, Inc. …

Category:  Health Go Health

Gilead Sciences, Inc.

WEBIR Contact. Gilead Investor Relations. (650) 574-3000. [email protected].

Category:  Health Go Health

Gilead Sciences, Inc.

WEB- Veklury is Now the First Approved Antiviral Treatment for Patients Across all Stages of Renal Disease - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that …

Category:  Health Go Health

Gilead Joins First-of-its-Kind Public-Private Initiative to Improve

WEB- Public-Private Effort to Shift Traditional Model of Hepatitis Management to Primary Care and Help to Expand Care to More People in Need - Gilead Sciences, Inc. …

Category:  Health Go Health

Gilead Sciences to Present at Upcoming Investor Conferences

WEBGilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: TD Cowen Annual Health Care …

Category:  Health Go Health

Gilead Sciences, Inc.

WEB– Gilead Will Provide up to $5 Million in Global Grant Funding to Immediately Support Public Education and Vaccine Hesitancy Communications, a Public Policy …

Category:  Health Go Health

Gilead Sciences, Inc.

WEBFOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $3 million in grant funding to eight …

Category:  Health Go Health

Gilead Sciences, Inc.

WEBGilead Sciences, Inc. (Nasdaq: GILD) today announced an $85 million contribution to the Gilead Foundation to further the company's vision of creating a …

Category:  Health Go Health

Gilead Sciences, Inc.

WEBIR Contact. Gilead Investor Relations. (650) 574-3000. [email protected].

Category:  Health Go Health

Gilead Sciences, Inc.

WEBFOSTER CITY, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will share 29 presentations, …

Category:  Health Go Health

Gilead Sciences, Inc.

WEB– $6 Million USD in Funding Will Help Address Health Disparities Among Indigenous Communities with a Focus on HIV and Viral Hepatitis – Gilead Sciences Inc. …

Category:  Health Go Health

Gilead Sciences, Inc.

WEB– Gilead Will Provide $4.5 Million in Funding to Help Improve Health Outcomes for Black Americans in the Southern United States – – Investment Reflects …

Category:  Health Go Health